f

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore. Excepteur sint lorem cupidatat.

You may like:

Psoriatic Arthritis: Understanding Patient Perspectives and Providing Patient-Centered Care

Week 1

Useful Expressions

Tools for Professional Approach: It’s not just about learning, it’s about having the confidence to use English in real life and upgrade your business communication skills.

3 videos, 1 audio
Video: Crowdsourcing
Video: Collocations For Job Interview
Audio: Listening Exercise
Graded: Advanced Business Principles

Week 2

Diplomatic Language

Tools for Professional Approach - Step 2: It’s not just about learning, it’s about having the confidence to use English in real life and upgrade your business communication skills.

2 videos, 1 reading
Graded: Information Technology Terms

Psoriatic Arthritis: Understanding Patient Perspectives and Providing Patient-Centered Care

This 45-minute long, engaging enduring activity was designed for clinicians who treat patients with psoriasis and psoriatic arthritis to engage, inform, and educate the participants on best practices in approaches to discuss with patients their beliefs about psoriatic arthritis and expectations for disease treatment and management, shared decision making regarding goals of treatment and treatment plan, and coordination of care between dermatology providers and rheumatology providers in management of patients with PsA. The patient was put in the center of the curriculum in a series of short videos featuring the patient with psoriasis and PsA and his interactions with the healthcare providers.

  • Richard Martin, MD, MA
    Professor of Medicine, Rheumatology
    Michigan State University College of Human Medicine
    Grand Rapids, Michigan

  • April W. Armstrong, MD, MPH
    Associate Dean for Clinical Research,
    Associate Professor of Dermatology,
    Director of Clinical Research,
    Southern California Clinical and Translational Science Institute
    Director of Clinical Trials and Outcomes Research,
    Director of Psoriasis Program,
    Department of Dermatology
    Keck School of Medicine
    University of Southern California
    Los Angeles, California



Disclosure and Conflict of Interest Resolution

Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s)*. For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias. Disclosures appear below as they were at the time of this activity.

*The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing health care goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.

The following individuals have indicated that neither they nor their spouses/partners have had, in the past 12 months, financial relationship(s) with commercial interests relative to the content of this CME activity:

  • Planners (Forefront Collaborative): Sydney Pate and Marianna Shershneva, MD, PhD

The following individuals have disclosed that they and/or their spouse/partner has had a financial relationship in the past 12 months:

  • Faculty:  April Armstrong, MD, has consulted for Jassen, Pfizer, Celgene, Merck, and Lilly. She has been on a speaker’s bureau for AbbVie and has contracted research for Amgen, AbbVie, Jassen, and Lilly.
  • Faculty: Richard Martin, MD, MA, has contracted research for Amgen clinical trials.

As a result of participation in this educational activity, participants should increase their ability to:

  • Discuss with patients their beliefs about PsA, perceptions of disease severity, understanding of likely disease course, benefit/risk profiles of personalized treatment options, and expectations in respect to therapeutic outcomes

  • Effectively engage patients with PsA in shared decision making regarding goals of treatment, development of PsA treatment plan, and treatment modification

  • Develop a patient-centered approach to coordination of care between dermatology providers and rheumatology providers in management of patients with PsA

Resources

Unless otherwise specifically prohibited, you may temporarily download one copy of the materials for personal, noncommercial use. You may not modify or copy the materials, use them for any commercial purpose or public display (commercial or noncommercial), remove any copyright or other proprietary notations, or transfer the materials to another person or online site.  

Activity Information

Target Audience
The target audience for this activity was dermatologists and rheumatologists. Other clinicians, including physician assistants and nurse practitioners who treat patients with PsA may have benefited from participation in the proposed activities.  

Accreditation Statement
Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Forefront Collaborative designated this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Content Review
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative or Pfizer.

The content of this educational activity was independently reviewed by peer-physicians and a patient with psoriasis and psoriatic arthritis. The reviewers of this activity have no relevant financial relationships to disclose. 

This continuing medical education activity included reference(s) to unlabeled or unapproved uses of drugs or devices.

Provider
This activity is provided by Forefront Collaborative in collaboration with Interstate Postgraduate Medical Association.

Commercial Support
This activity was supported by an educational grant from Pfizer